Home › Hodgkin Lymphoma
Hodgkin Lymphoma clinical trials recruiting in the U.S.
62 studies for Hodgkin Lymphoma are recruiting participants at sites across the United States.
Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.
Cities with the most studies
- Houston, TX14 studies
- New York City, NY11 studies
- Boston, MA9 studies
- Baldwin Park, CA9 studies
- Miami, FL8 studies
- Memphis, TN7 studies
- Philadelphia, PA6 studies
- Greenburgh, NY5 studies
- Mountain View, CA5 studies
- Madison, WI4 studies
- Atlanta, GA4 studies
- Milwaukee, WI4 studies
- Washington, DC4 studies
- Edison, NJ4 studies
- Queens, NY4 studies
- Aurora, CO4 studies
- Durham, NC4 studies
- Orange, CA3 studies
- Columbus, OH3 studies
- Chicago, IL3 studies
- Indianapolis, IN3 studies
- San Francisco, CA3 studies
- Denver, CO3 studies
- Seattle, WA3 studies
- Baltimore, MD3 studies
- Cincinnati, OH3 studies
- Los Angeles, CA3 studies
- Minneapolis, MN3 studies
- Staten Island, NY3 studies
- East Norwalk, CT3 studies
- New Rochelle, NY3 studies
- Sacramento, CA3 studies
By state
- California15 studies
- Colorado5 studies
- Florida12 studies
- Georgia6 studies
- Illinois4 studies
- Indiana4 studies
- Maryland5 studies
- Massachusetts9 studies
- Minnesota4 studies
- New Jersey5 studies
- New York15 studies
- North Carolina6 studies
- Ohio4 studies
- Pennsylvania7 studies
- Tennessee8 studies
- Texas15 studies
- Washington4 studies
- Wisconsin8 studies
Recently updated studies
Tissue Collection for Studies of Lymph Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT01676805Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT03418038Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT02682667Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06398457Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT03618550A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05615636Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
RecruitingPhase 1
Ages 18 to 100 · All sexes · Updated Sep 15, 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 14, 2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05272384Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT07444632Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT06421987Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
RecruitingPhase 2
Ages 2 to 21 · All sexes · Updated Aug 31, 2026 · NCT07551583Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Recruiting
All ages · All sexes · Updated Aug 21, 2026 · NCT07514819ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07021989CD45BE-HSPC + CART-45 Cells
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07451054Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
RecruitingPhase 1/2
Ages 12 to 80 · All sexes · Updated Aug 7, 2026 · NCT05092451ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06090864Personalized NK Cell Therapy in CBT
RecruitingPhase 2
Ages 15 to 80 · All sexes · Updated Jul 30, 2026 · NCT02727803The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07285044A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07020533A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT06150664Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Jul 20, 2026 · NCT06176690Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06580002Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
RecruitingPhase 3
Ages 16 to 69 · All sexes · Updated Jul 8, 2026 · NCT04685616A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.